Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.56 |
| ▸ | CNR1 | P21554 | 2/20 | 0.50 |
| ▸ | CNR2 | P34972 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | JAK2 | O60674 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HTR1B | P28222 | 4/20 | 0.45 |
| ▸ | ESR1 | P03372 | 6/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.44 |
| ▸ | HTR1D | P28221 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5596066 | 0.91 | IDO1 (0.54) | IDO1CNR1CNR2GAAMAPT | |
| SCHEMBL9315152 | 0.89 | IDO1 (0.53) | IDO1CNR1CNR2GAAMAPT | |
| SCHEMBL30003085 | 0.89 | IDO1 (0.71) | IDO1CNR1CNR2GAAMAPT | |
| SCHEMBL2023756 | 0.89 | IDO1 (0.71) | IDO1CNR1CNR2GAAMAPT | |
| SCHEMBL8863052 | 0.88 | CYP2A6 (0.56) | CNR1CNR2CYP2A6HTR1BHTR1D | |
| SCHEMBL30503979 | 0.88 | CYP2A6 (0.56) | CNR1CNR2CYP2A6HTR1BHTR1D | |
| SCHEMBL8746001 | 0.88 | CNR1 (0.53) | IDO1CNR1CNR2MAPTLMNA | |
| SCHEMBL9697360 | 0.88 | CNR1 (0.53) | IDO1CNR1CNR2MAPTLMNA | |
| SCHEMBL9353430 | 0.88 | CNR1 (0.53) | IDO1CNR1CNR2MAPTLMNA | |
| SCHEMBL9578532 | 0.88 | CNR1 (0.53) | IDO1CNR1CNR2MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103097426-B | Epoxy compounds, solidification compound and cured article thereof | DIC CORP. (JP) | 2016-03-02 | — | — | CN | disclosed |
| EP-2557103-B1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DAINIPPON INK & CHEMICALS (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-8519065-B2 | Epoxy compound, curable composition, and cured product thereof | DIC CORPORATION (JP) | 2013-08-27 | — | — | US | disclosed |
| US-20130144030-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2013-06-06 | — | — | US | disclosed |
| CN-103097426-A | Epoxy compound, curable composition, and cured product thereof | DAINIPPON INK & CHEMICALS | 2013-05-08 | — | — | CN | disclosed |
| EP-2557103-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DIC Corporation (JP) | 2013-02-13 | — | — | EP | disclosed |
| EP-2448864-A2 | SILICA-BASED PARTICLE COMPOSITION | Nalco Company (US) | 2012-05-09 | — | — | EP | disclosed |
| WO-2011028498-A2 | CALCIUM-BASED CARRIER PARTICLES | NALCO COMPANY (US) | 2011-03-10 | — | — | WO | disclosed |
| WO-2011028496-A2 | CALCIUM BASED CARRIER PARTICLES | NALCO COMPANY (US) | 2011-03-10 | — | — | WO | disclosed |
| WO-2011028469-A2 | CALCIUM BASED CARRIER PARTICLES | NALCO COMPANY (US) | 2011-03-10 | — | — | WO | disclosed |
| US-20100331431-A1 | SILICA-BASED PARTICLE COMPOSITION | NALCO COMPANY | 2010-12-30 | — | — | US | disclosed |
| US-20100330366-A1 | SILICA-BASED PARTICLE COMPOSITION | NANOSPECIALTIES, LLC | 2010-12-30 | — | — | US | disclosed |
| US-7612217-B2 | Sulfonium compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-11-03 | — | — | US | disclosed |
| US-7612217-B2 | Sulfonium compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-11-03 | — | — | US | disclosed |
| US-7439006-B2 | Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-10-21 | — | — | US | disclosed |
| US-7439006-B2 | Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-10-21 | — | — | US | disclosed |
| US-20080081925-A1 | Sulfonium compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-04-03 | — | — | US | disclosed |
| US-20080081925-A1 | Sulfonium compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-04-03 | — | — | US | disclosed |
| US-20080076063-A1 | Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080076063-A1 | Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081925-A1 | Sulfonium compound | SLCO2A1, AFF2, SLCO2B1 | IDO1 4394/4885CNR1 508/4885CNR2 525/4885 |
| US-20080076063-A1 | Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same | SLC26A3, HCN3, NHERF1 | IDO1 4594/4885CNR1 589/4885CNR2 942/4885 |
| US-20130144030-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | HEATR1, EEF1A1, EPN1 | IDO1 4224/4885CNR1 398/4885CNR2 965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.